Who We Are
HeartMatrix AI is a technology-driven company specializing in advanced diagnostic solutions for cardiovascular diseases. Established in 2024 by leading experts in clinical medicine, computer science, and mechanical engineering, the company is at the forefront of the new era in medical diagnostics. This era is defined by the convergence of data-driven technologies—such as deep learning and machine learning—and knowledge-driven approaches, including computational medicine, computer-aided engineering, and digital twin modeling. Together, these innovations form the foundation of computational medicine. HeartMatrix AI is dedicated to developing a world-class imaging and data analysis platform for cardiovascular and cardiac care. Leveraging artificial intelligence and digital simulation, the company has achieved fully automated generation of image-derived morphological and functional metrics, advancing precision in cardiac diagnostics.
R&D
2024
Development

2024

2024,Fully automated CTA-suite (AI-QCT/AI-CPA/CT-FFR) was launched.
Future
HeartMatrix’s vision is to build a universal AI-based RIS platform that can handle most routine analysis tasks in radiology departments, including cardiac CTA/MRA, intracranial CTA/MRA, thoracic CT/MRI, and abdominal CT/MR analysis, etc. This platform aims to address the current challenges faced by radiologists and clinicians, such as varying levels of diagnostic accuracy and time-consuming image interpretation. By developing a multimodal, multi-organ medical imaging auto-annotation system, we aim to solve issues such as inconsistent gold standards, high annotation costs, and difficulties in data curation within medical imaging. Leveraging our years of expertise in deep learning and numerical simulation, our first flagship product, the CTA-suite, has already achieved a closed-loop, fully automated, high-precision morphological and functional analysis platform for coronary and cardiac imaging. In the future, we will quickly transfer the success and accumulated technology from this product to other imaging analyses. The company aims to build the world’s most accurate AI RIS platform within five years.